GISMO 是一种约 Tic Tac 大小的可食用胃肠智能胶囊，可沿人体肠道移动，每 20 秒进行一次化学读数，并把结果发送到腰带接收器；它用于测量氧化还原平衡，以早期提示炎症或病变组织。传统结肠镜约需 30 分钟、花费数百英镑且具有侵入性，而 PillCam 已在全球超过 400 万名患者中使用，但视觉成像之外，气体、酸度、炎症分子和化学反应输出往往更关键。
传感趋势正从成像转向实时环境测量：2018 年的试点胶囊首次在肠道内回传氧气、氢气和二氧化碳读数，并能检测膳食纤维变化后的微生物发酵改变。2023 年马里兰大学胶囊用 Nafion 涂层金电极实时检测硫化氢，2024 年南加州大学药丸用光电子传感器测量氧气和氨并结合神经网络实现毫米级定位；Atmo Biosciences 的发酵气体胶囊进入临床开发，早期安全研究称其灵敏度为标准呼气测试的 3,000 倍。
下一阶段把诊断与治疗结合：MIT 在 2024 年开发仿头足类喷射推进的胶囊，把药物直接泵入消化道壁，并获得 ARPA-H 6,600 万美元、为期五年的资助，用于口服 mRNA 治疗和电疗法递送。主要瓶颈是电源和材料：常规银氧化物电池限制微型化并产生电子废物，而 2023 年首个可充电可食用电池仅提供 0.65 伏、48 微安、持续 12 分钟，随后可食用晶体管仍面临能量低、速度慢、无线信号被组织吸收和监管复杂等障碍。
GISMO is an edible gastrointestinal smart capsule about the size of a Tic Tac, moving through the human gut, taking a chemical reading every 20 seconds, and sending results to a belt receiver; it measures redox balance to give early warning of inflamed or diseased tissue. A standard colonoscopy takes about 30 minutes, costs several hundred pounds, and is invasive, while PillCam has been used in more than 4 million patients worldwide, but beyond visual imaging, gases, acidity, inflammatory molecules, and chemical-reaction outputs are often more critical.
The sensing trend is shifting from imaging to real-time environmental measurement: a 2018 pilot capsule first transmitted oxygen, hydrogen, and carbon dioxide readings inside the gut and detected microbial fermentation changes after dietary-fibre changes. In 2023 a University of Maryland capsule used a Nafion-coated gold electrode to detect hydrogen sulphide in real time, and in 2024 a University of Southern California pill used optoelectronic sensors for oxygen and ammonia plus neural networks for millimetre-scale mapping; Atmo Biosciences’ fermentation-gas capsule has entered clinical development, with an earlier safety study claiming 3,000-fold greater sensitivity than standard breath testing.
The next stage combines diagnosis with therapy: in 2024 MIT developed a capsule modelled on cephalopod jet propulsion to pump drugs directly into the digestive-tract wall, and received $66 million from ARPA-H over five years for oral mRNA treatments and electroceutical delivery. The main bottlenecks are power and materials: conventional silver-oxide batteries limit miniaturisation and create electronic waste, while the first rechargeable edible battery in 2023 delivered only 0.65 volts and 48 microamps for 12 minutes, and later edible transistors still face low energy, slow speed, tissue absorption of wireless signals, and regulatory complexity.
Source: Tomorrow’s medical sensors might come served with dinner
Subtitle: Listening your gut could involve riboflavin batteries and toothpaste transistors
Dateline: 5月 28, 2026 05:19 上午